NEWSROOM

July 14, 2009

PCMA Vows Continued Support for Real Biogenerics Reform Despite Committee Vote

Launches New Radio Ad: America Wants the Change it Voted For 

(Washington, DC)- In response to last night’s U.S. Senate Health, Education, Labor and Pensions (HELP) Committee vote to allow biologic drugs 12 years of market protection before generic versions can compete, the Pharmaceutical Care Management Association (PCMA) launched a new radio ad campaign which says that “America wants the change it voted for” in health reform.  

PCMA President and CEO Mark Merritt issued the following statement:

“Despite this setback, the biogenerics debate marches on and is a bellwether for Washington’s capacity for real health reform.  Either Congress will side with the voters who expect real change – the seniors, consumers, employers and unions who support meaningful biogenerics reform – or it will let health costs continue to soar as a courtesy to special interests.

“Because this proposal would grant manufacturers almost twice the monopoly pricing power that the President requested and ignores the Federal Trade Commission report which found that not even one year is necessary to protect incentives to innovate, it is hard to conceive that it will be part of any final ‘reform’ legislation in its current state.”

###